Acyl-CoA thioesterase 8 is a specific protein related to nodal metastasis and prognosis of lung adenocarcinoma

被引:17
|
作者
Jung, Woon Yong [1 ]
Kim, Young Hye [1 ]
Ryu, Young Joon [1 ]
Kim, Baek-Hui [1 ]
Shin, Bong Kyung [1 ]
Kim, Aeree [1 ]
Kim, Han Kyeom [1 ]
机构
[1] Korea Univ, Coll Med, Dept Pathol, Seoul 152703, South Korea
关键词
Lung; Adenocarcinoma; Neoplasm metastasis; Prognosis; Proteomics; PROLIFERATOR-ACTIVATED RECEPTOR; PEROXISOMAL BETA-OXIDATION; MICROSOMAL EPOXIDE HYDROLASE; ACID-BINDING PROTEIN; CLOFIBRIC ACID; TUMOR SIZE; CANCER; INDUCTION; RAT; ELECTROPHORESIS;
D O I
10.1016/j.prp.2013.02.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Metastasis is a major cause of cancer recurrence or death. This study attempted to quantitatively identify different proteins in metastatic lung adenocarcinoma. The NIT quotient [number of metastatic lymph nodes (n)/tumor diameter (cm)] was used to select samples with an extreme metastatic phenotype. Among the six fresh frozen lung adenocarcinoma specimens, the three showing the highest NIT quotient represented the metastatic group, and others with the greatest tumor diameters without metastasis represented the non-metastatic group. After 2-dimensional electrophoresis, the significantly different protein spots were selected by image analysis and analyzed with MALDI-TOF mass spectrometry. Acyl-CoA thioesterase 8 isoform c (ACOT8) was one of most overexpressed proteins in the metastatic group, and it was validated by Western blot and immunohistochemical staining on 108 paraffin-embedded tumor samples. High ACOT8 expression was correlated with lymph node metastasis (p = 0.002), recurrence (p = 0.034), predominant histologic subtypes (p = 0.007), and higher stage (p = 0.005). In multivariate analysis, high ACOT8 expression was significantly associated with increased risks of lymph node metastasis (p = 0.009) and cancer-related death (p = 0.030), independent of clinical factors. ACOT8 may be a candidate prognostic biomarker and therapeutic target of lung adenocarcinoma. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [41] KRAS mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
    Klikovits, Thomas
    Lohinai, Zoltan
    Moldvay, Judit
    Ostoros, Gyula
    Raso, Erzsebet
    Timar, Jozsef
    Fabian, Katalin
    Kovalszky, Ilona
    Kenessey, Istvan
    Aigner, Clemens
    Renyi-Vamos, Ferenc
    Klepetko, Walter
    Hoda, Mir Alireza
    Hegedus, Balazs
    Doeme, Balazs
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 770 - 770
  • [42] Low-density lipoprotein receptor related protein 11 (LRP11) contributes to poor prognosis in lung adenocarcinoma
    Kiwaki, Takumi
    Kawaguchi, Makiko
    Kataoka, Hiroaki
    Fukushima, Tsuyoshi
    CANCER SCIENCE, 2024, 115 : 1396 - 1396
  • [43] A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
    Feng, Jinteng
    Xu, Longwen
    Zhang, Shirong
    Geng, Luying
    Zhang, Tian
    Yu, Yang
    Yuan, Rui
    He, Yusheng
    Nan, Zhuhui
    Lin, Min
    Guo, Hui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
    Lohinai, Zoltan
    Klikovits, Thomas
    Moldvay, Judit
    Ostoros, Gyula
    Raso, Erzsebet
    Timar, Jozsef
    Fabian, Katalin
    Kovalszky, Ilona
    Kenessey, Istvan
    Aigner, Clemens
    Renyi-Vamos, Ferenc
    Klepetko, Walter
    Dome, Balazs
    Hegedus, Balazs
    SCIENTIFIC REPORTS, 2017, 7
  • [45] KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
    Zoltan Lohinai
    Thomas Klikovits
    Judit Moldvay
    Gyula Ostoros
    Erzsebet Raso
    Jozsef Timar
    Katalin Fabian
    Ilona Kovalszky
    István Kenessey
    Clemens Aigner
    Ferenc Renyi-Vamos
    Walter Klepetko
    Balazs Dome
    Balazs Hegedus
    Scientific Reports, 7
  • [46] Integrated analysis of single-cell and bulk RNA-sequencing identifies a metastasis-related gene signature for predicting prognosis in lung adenocarcinoma
    Cao, Xu
    Xi, Jingjing
    Wang, Congyue
    Yu, Wenjie
    Wang, Yanxia
    Zhu, Jingjing
    Xu, Kailin
    Pan, Di
    Chen, Chong
    Han, Zhengxiang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [47] Sex-dependent toxicity of a novel acyl-CoA:cholesterol acyltransferase inhibitor, YIC-C8-434, in relation to sex-specific forms of cytochrome P450 in rats
    Kaneko, K
    Uchida, K
    Kobayashi, T
    Miura, K
    Tanokura, K
    Hoshino, K
    Kato, I
    Onoue, M
    Yokokura, T
    TOXICOLOGICAL SCIENCES, 2001, 64 (02) : 259 - 268
  • [48] Dishevelled Segment Polarity Protein 3: A Novel Prognosis-related Marker in Pan-driver-gene-negative Lung Adenocarcinoma
    Cui, Yongmei
    Tang, Cuilan
    Guo, Jinrui
    Sun, Yu
    Ke, Zunfu
    JOURNAL OF CANCER, 2023, 14 (16): : 3028 - 3038
  • [49] Ly6/uPAR-Related Protein C4.4A as a Marker of Solid Growth Pattern and Poor Prognosis in Lung Adenocarcinoma
    Jacobsen, Benedikte
    Muley, Thomas
    Meister, Michael
    Dienemann, Hendrik
    Christensen, Ib Jarle
    Santoni-Rugiu, Eric
    Laerum, Ole Didrik
    Ploug, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (02) : 152 - 160
  • [50] Adipocyte-specific Inactivation of Acyl-CoA Synthetase Fatty Acid Transport Protein 4 (Fatp4) in Mice Causes Adipose Hypertrophy and Alterations in Metabolism of Complex Lipids under High Fat Diet
    Lenz, Lena-Solveig
    Marx, Jana
    Chamulitrat, Walee
    Kaiser, Iris
    Groene, Hermann-Josef
    Liebisch, Gerhard
    Schmitz, Gerd
    Elsing, Christoph
    Straub, Beate K.
    Fuellekrug, Joachim
    Stremmel, Wolfgang
    Herrmann, Thomas
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (41) : 35578 - 35587